Logo-apb

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308 
pISSN: 2228-5881 

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by
Letter to Editor

Bacteria associated with prostate cancer progression and new strategy in the treatment
Fathimath Ina Shareef ORCID, Kannan Subbaram* ORCID, Razana Faiz ORCID, Sheeza Ali ORCID
Adv Pharm Bull. doi: 10.34172/apb.025.45862 | Published on: 2025 Jun 05
Edit InpressPDF
Short Communication

Assessing the potential of generative Artificial Intelligence models to assist experts in the development of pharmacokinetic models
Sergio Sánchez Herrero* ORCID, Laura Calvet Liñan* ORCID
Adv Pharm Bull. doi: 10.34172/apb.025.43852 | Published on: 2025 Jun 03
Edit InpressPDF
Editorial

The impact beyond academia: patent citations of the advanced pharmaceutical bulletin
Mihály Hegedűs ORCID, Mehdi Dadkhah* ORCID, Lóránt Dénes Dávid ORCID
Adv Pharm Bull. doi: 10.34172/apb.025.45761 | Published on: 2025 Jun 03
Edit InpressPDF
Review Article

M2 macrophages-based immunotherapy: A new therapeutic approach in liver fibrosis
Wahyu Widowati* ORCID, Adilah Hafizha Nur Sabrina, Annisa Firdaus Sutendi, Fadhilah Haifa Zahiroh, Teresa Liliana Wargasetia, Ita Margaretha Nainggolan, Elham Rismani* ORCID, Massoud Vosough* ORCID
Adv Pharm Bull. doi: 10.34172/apb.025.43855 | Published on: 2025 Jun 02
Edit InpressPDF
Review Article

Lung cancer immunotherapy approaches: from clinical testing to future advances
Mayuri Bhattacharyya ORCID, Suktilang Majaw* ORCID
Adv Pharm Bull. doi: 10.34172/apb.025.45104 | Published on: 2025 Jun 02
Edit InpressPDF
Mini Review

Monoclonal antibody-anchored quantum dots-based delivery strategies for glioblastoma treatment: Challenges and applications
CHANDRAKANTSING VIJAYSING PARDESHI* ORCID, Dipak Bhalchandra Bari* ORCID
Adv Pharm Bull. doi: 10.34172/apb.025.44026 | Published on: 2025 Jun 02
Edit InpressPDF
Review Article

An Overview on Lipid Nanocapsules: Exploring the Role in Precision Cancer Treatment and Lymphatic Drug Distribution
Mahesha Keerikkadu ORCID, Pragathi Devananda Bangera ORCID, Vamshi Krishna Tippavajhala ORCID, Mahalaxmi Rathnanand* ORCID
Adv Pharm Bull. doi: 10.34172/apb.025.45109 | Published on: 2025 Jun 01
Edit InpressPDF
Review Article

Biomedical Applications of Carbon-Based Nanomaterials: Exploring Recent Advances in Therapeutics, Diagnostics, and Tissue Engineering
Afsona Parveen ORCID, Arnab Chatterjee ORCID, Prithviraj Karak* ORCID
Adv Pharm Bull. doi: 10.34172/apb.025.44083 | Published on: 2025 May 31
Edit InpressPDF
Review Article

Responsive Nano-structured Cubosomes: Advancements and Therapeutic Applications
Ishal Miranda ORCID, Biyas Misra ORCID, Manasa C M, Geetha Nayak ORCID, Likhitha U ORCID, Usha Y Nayak* ORCID
Adv Pharm Bull. doi: 10.34172/apb.025.43330 | Published on: 2025 May 31
Edit InpressPDF
Research Article

Hypoxic exosomes alleviated the spinal cord injury after ischemic/reperfusion in a rat model
Mahdiyeh Asadzadeh Bavil ORCID, Gollam Hossein Farjah, Bagher Pourheydar, Reza Rahbarghazi* ORCID
Adv Pharm Bull. doi: 10.34172/apb.025.43118 | Published on: 2025 May 30
Edit InpressPDF
Research Article

PI3K signaling pathway inhibitor affects myeloma cells in a culture-dependent manner
Mehrnaz Janfada ORCID, Sadaf Vahdat* ORCID, Saeid Kaviani* ORCID
Adv Pharm Bull. doi: 10.34172/apb.025.42774 | Published on: 2025 Apr 24
Edit InpressPDF
Research Article

Synergistic enhancement of osimertinib efficacy in non-small cell Lung cancer cells through Epigallocatechin-3-gallate: mechanistic insights into YAP/TEAD/CTGF axis inhibition

Ashwini Somayaji* ORCID, C S Shastry
Adv Pharm Bull. doi: 10.34172/apb.43809 | Published on: 2025 Mar 23
Edit InpressPDF
Letter to Editor

Inhibition of COX-2 and PI3K/AKT Pathways to Prevent Cancer Metastasis
Punet Kumar* ORCID, Sangam Singh ORCID
Adv Pharm Bull. doi: 10.34172/apb.44038 | Published on: 2025 Mar 23
Edit InpressPDF
Research Article

Inhibitory Effects of Citrus-Derived Flavonoids Hesperidin and Hesperetin on SARS-CoV-2 spike-Mediated Syncytia Formation Using In vitro Cell Model
Dennaya Kumara ORCID, Hayfa Salsabila Harsan, Endah Puji Septisetyani* ORCID, Pekik Wiji Prasetyaningrum ORCID, Komang Alit Paramitasari ORCID, Mukh Syaifudin ORCID, Muthi Ikawati ORCID, Okid Parama Astirin ORCID, Edy Meiyanto ORCID
Adv Pharm Bull. doi: 10.34172/apb.44060 | Published on: 2025 Mar 09
Edit InpressPDF
Review Article

Food as medicine: Curbing type-2 diabetes prevalence through consumption of high amylose starchy foods in Sub-Saharan Africa
Muyiwa S Adegbaju, Ifeoluwa E Adegbaju, Issah A Memunat, Fatimatou Saccoh, Ademola A Falade, James R Lloyd, Olanrewaju Morenikeji* ORCID
Adv Pharm Bull. doi: 10.34172/apb.025.43630 | Published on: 2025 Feb 22
Edit InpressPDF